What Is CJC-1295?
CJC-1295 is a synthetic growth hormone–releasing hormone (GHRH) analog studied in laboratory settings for its interaction with growth hormone signaling pathways. Researchers investigate CJC-1295 for its prolonged half-life and ability to stimulate endogenous growth hormone release under controlled experimental conditions.
This compound is supplied strictly for research and laboratory use only and is not intended for human or veterinary consumption.
CJC-1295 Research Applications
CJC-1295 is widely researched in experimental models related to:
-
Growth hormone secretion pathways
-
Muscle tissue development mechanisms
-
Fat metabolism signaling research
-
Cellular regeneration studies
-
Endocrine system research
Its stability and receptor affinity make it a valuable compound for peptide research laboratories.
CJC-1295 No DAC vs DAC (Research Context)
In research environments, CJC-1295 is commonly studied in No DAC form, allowing scientists to observe rapid GHRH signaling without extended albumin binding. This distinction is important when designing peptide interaction studies.
Product Specifications
-
Compound Name: CJC-1295
-
Purity: ≥99% (HPLC tested)
-
Form: Lyophilized powder
-
Storage: Refrigerated upon reconstitution
-
Category: Research peptide
-
Use: Laboratory and scientific research only
Quality & Testing
Each batch of CJC-1295 undergoes independent third-party testing to confirm purity, identity, and stability. Certificates of Analysis (COA) are available upon request.
Compliance & Disclaimer (Very Important)
This product is not a drug, not a dietary supplement, and not intended for human consumption.
CJC-1295 is sold exclusively for laboratory research purposes in compliance with applicable regulations in the USA, UK, Europe, and Canada.





Reviews
There are no reviews yet.